More recently, we have demonstrated that visfatin not only directly influences breast cancer progression but also indirectly affects breast cancer through GDF-15 secretion in ADSCs, thus promoting breast cancer malignant behavior [33]. Here, NAMPT is linked to breast carcinoma.